Kalidas Shetty Selected Research

Hyperglycemia

1/2023	Integrated metabolite analysis and health-relevant in vitro functionality of white, red, and orange maize (Zea mays L.) from the Peruvian Andean race Cabanita at different maturity stages.
10/2021	Primary and Phenolic Metabolites Analyses, In Vitro Health-Relevant Bioactivity and Physical Characteristics of Purple Corn (Zea mays L.) Grown at Two Andean Geographical Locations.
1/2021	Phenolic Bioactives From Plant-Based Foods for Glycemic Control.
6/2019	Evaluation of phenolic antioxidant-linked in vitro bioactivity of Peruvian corn (Zea mays L.) diversity targeting for potential management of hyperglycemia and obesity.
10/2017	Improving phenolic bioactive-linked anti-hyperglycemic functions of dark germinated barley sprouts (Hordeum vulgare L.) using seed elicitation strategy.
11/2013	Potential of Chilean native corn (Zea mays L.) accessions as natural sources of phenolic antioxidants and in vitro bioactivity for hyperglycemia and hypertension management.
2/2013	Phenolic-linked biochemical rationale for the anti-diabetic properties of Swertia chirayita (Roxb. ex Flem.) Karst.
10/2011	Anti-hyperglycemia properties of Tea (Camellia sinensis) bioactives using in vitro assay models and influence of extraction time.
10/2010	Potential of cranberry powder for management of hyperglycemia using in vitro models.
10/2010	Evaluation of antiproliferative, anti-type 2 diabetes, and antihypertension potentials of ellagitannins from strawberries (Fragaria × ananassa Duch.) using in vitro models.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kalidas Shetty Research Topics

Disease

17	Hyperglycemia 01/2023 - 01/2004
13	Hypertension (High Blood Pressure) 02/2014 - 01/2005
9	Type 2 Diabetes Mellitus (MODY) 02/2013 - 01/2005
2	Dental Caries (Decay, Dental) 05/2019 - 01/2004
2	Chronic Disease (Chronic Diseases) 01/2014 - 01/2004
2	Diabetes Complications 01/2005 - 01/2004
1	Infections 01/2023
1	Foodborne Diseases 06/2022
1	Colitis 01/2022
1	Ulcerative Colitis 01/2022
1	Nervous System Diseases (Neurological Disorders) 01/2021
1	Insulin Resistance 01/2021
1	Non-alcoholic Fatty Liver Disease 10/2020
1	Dysbiosis 10/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2020
1	Dyslipidemias (Dyslipidemia) 10/2020
1	Obesity 06/2019
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 05/2019
1	Parkinson Disease (Parkinson's Disease) 10/2009
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2004
1	Peptic Ulcer (Peptic Ulcers) 01/2004
1	Arthritis (Polyarthritis) 01/2004
1	Bacterial Infections (Bacterial Infection) 01/2004
1	Neoplasms (Cancer) 01/2004
1	Urinary Tract Infections (Urinary Tract Infection) 01/2004
1	Diabetes Mellitus 01/2004
1	Communicable Diseases (Infectious Diseases) 01/2004

Drug/Important Bio-Agent (IBA)

15	AntioxidantsIBA 01/2023 - 01/2004
9	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 11/2013 - 01/2005
8	GlucosidasesIBA 01/2023 - 10/2010
8	Amylases FDA Link 01/2023 - 01/2004
8	EnzymesIBA 01/2021 - 01/2005
8	alpha-Glucosidases (Acid Maltase)IBA 06/2010 - 01/2005
7	alpha-AmylasesIBA 06/2010 - 01/2006
5	PhytochemicalsIBA 02/2014 - 01/2004
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2004
3	CarbohydratesIBA 01/2021 - 01/2005
3	Ethanol (Ethyl Alcohol)IBA 02/2013 - 04/2009
3	1,1-diphenyl-2-picrylhydrazylIBA 02/2013 - 08/2009
2	TeaIBA 01/2022 - 10/2011
2	AcidsIBA 05/2019 - 10/2010
2	SugarsIBA 10/2010 - 06/2008
2	Pancreatic alpha-AmylasesIBA 01/2006 - 01/2005
1	Histamine (Histamine Dihydrochloride)FDA Link 06/2022
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2022
1	Dextran SulfateIBA 01/2022
1	Free RadicalsIBA 01/2021
1	Nucleic AcidsIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	LipidsIBA 01/2021
1	Anthocyanins (Anthocyanin)IBA 10/2020
1	Lipase (Acid Lipase)FDA Link 06/2019
1	phenolic acidIBA 10/2017
1	allicinIBA 02/2014
1	S-allylcysteine (allyl cysteine)IBA 02/2014
1	2,2'- azino- di- (3- ethylbenzothiazoline)- 6- sulfonic acid (ABTS)IBA 11/2013
1	swertiamarinIBA 02/2013
1	amarogentinIBA 02/2013
1	HexanesIBA 02/2013
1	swerchirinIBA 02/2013
1	mangiferinIBA 02/2013
1	SolutionsIBA 02/2013
1	Complex MixturesIBA 02/2013
1	PowdersIBA 10/2010
1	Ellagic AcidIBA 10/2010
1	Hydrolyzable TanninsIBA 10/2010
1	Levodopa (L Dopa)FDA LinkGeneric 10/2009
1	Sweetening Agents (Sweeteners)IBA 06/2008
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 01/2005
1	Proline (L-Proline)FDA Link 01/2004
1	Starch (Cornstarch)IBA 01/2004

Therapy/Procedure

1	Therapeutics 01/2023
1	Glycemic Control 01/2021
1	Complementary Therapies (Alternative Medicine) 02/2014
1	Canes (Cane) 06/2008